From iPSC towards cardiac tissue-a road under construction

Area of Science:

• Stem cell biology
• Gene editing technologies
• Regenerative medicine

Background:

• Induced pluripotent stem cells (iPSC) enable the generation of diverse human cell types.
• Gene editing tools, such as CRISPR/CAS, enhance the utility of iPSCs.
• Significant advancements in disease modeling and pharmacology have been driven by iPSC technology.

Purpose of the Study:

• To review standard methods for generating iPSCs and differentiating them into cardiomyocytes.
• To discuss recent achievements in iPSC technology.
• To highlight current limitations and future perspectives in the field.

Main Methods:

• Review of established protocols for iPSC generation.
• Analysis of transduction methods for iPSC differentiation into cardiomyocytes.
• Synthesis of recent research findings and identified challenges.

Main Results:

• iPSC technology and CRISPR/CAS have revolutionized life sciences, particularly in disease modeling and pharmacology.
• Current limitations primarily stem from suboptimal culturing conditions that fail to mimic native cellular environments.
• Ongoing research aims to overcome these limitations for more effective iPSC applications.

Conclusions:

• The potential of iPSC-derived cells is vast, but practical challenges in culturing and differentiation persist.
• Further research is crucial to refine methods and fully harness the capabilities of iPSC technology.
• The field is progressing, but the development of optimal protocols remains an active area of investigation.